This report highlights zonisamide as a potential cause of serious cutaneous reactions as well as its cross‐reactivity with other sulfonamides. Here, we present a case of SJS ‐ TEN due to zonisamide, which was effectively treated with IVI g. Subsequently, the patient was transitioned to levetiracetam for seizure control.
CITATION STYLE
Vivar, K. L., Mancl, K., & Seminario‐Vidal, L. (2018). Stevens–Johnson syndrome/toxic epidermal necrolysis associated with zonisamide. Clinical Case Reports, 6(2), 258–261. https://doi.org/10.1002/ccr3.1288
Mendeley helps you to discover research relevant for your work.